SG11202110619XA - Mirikizumab for use in a method of treating crohn's disease - Google Patents
Mirikizumab for use in a method of treating crohn's diseaseInfo
- Publication number
- SG11202110619XA SG11202110619XA SG11202110619XA SG11202110619XA SG11202110619XA SG 11202110619X A SG11202110619X A SG 11202110619XA SG 11202110619X A SG11202110619X A SG 11202110619XA SG 11202110619X A SG11202110619X A SG 11202110619XA SG 11202110619X A SG11202110619X A SG 11202110619XA
- Authority
- SG
- Singapore
- Prior art keywords
- mirikizumab
- disease
- treating crohn
- crohn
- treating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962836910P | 2019-04-22 | 2019-04-22 | |
| PCT/US2020/028273 WO2020219314A1 (en) | 2019-04-22 | 2020-04-15 | Mirikizumab for use in a method of treating crohn's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202110619XA true SG11202110619XA (en) | 2021-11-29 |
Family
ID=70554215
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202110619XA SG11202110619XA (en) | 2019-04-22 | 2020-04-15 | Mirikizumab for use in a method of treating crohn's disease |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20220040299A1 (https=) |
| EP (1) | EP3958897B1 (https=) |
| JP (3) | JP7297930B2 (https=) |
| KR (2) | KR102869852B1 (https=) |
| CN (2) | CN113677366A (https=) |
| AU (2) | AU2020263238C1 (https=) |
| BR (1) | BR112021018930A2 (https=) |
| EA (1) | EA202192532A1 (https=) |
| IL (2) | IL286818B2 (https=) |
| MA (1) | MA55756A (https=) |
| MX (1) | MX2021012848A (https=) |
| SG (1) | SG11202110619XA (https=) |
| TW (2) | TW202515610A (https=) |
| UA (1) | UA128657C2 (https=) |
| WO (1) | WO2020219314A1 (https=) |
| ZA (1) | ZA202108094B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202515610A (zh) * | 2019-04-22 | 2025-04-16 | 美商美國禮來大藥廠 | 治療克隆氏症(crohn's disease)的方法 |
| KR20220066831A (ko) | 2020-11-16 | 2022-05-24 | 엔브이에이치코리아(주) | 습기경화형 접착제를 이용한 헤드라이닝 제조방법 및 이에 의해 제조되는 헤드라이닝 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR094877A1 (es) | 2013-03-08 | 2015-09-02 | Lilly Co Eli | Anticuerpos que se unen a il-23 |
| SG11201507483PA (en) | 2013-03-15 | 2015-10-29 | Amgen Inc | Methods for treating crohn's disease using an anti-il23 antibody |
| TWI811716B (zh) | 2015-09-18 | 2023-08-11 | 德商百靈佳殷格翰國際股份有限公司 | 治療發炎性疾病之方法 |
| US20190292265A1 (en) * | 2016-08-19 | 2019-09-26 | Janssen Biotech, Inc. | Methods of Treating Crohn's Disease with an Anti-NKG2D Antibody |
| KR20200037258A (ko) * | 2017-07-10 | 2020-04-08 | 람밤 메드-테크 엘티디. | 생물학적 약물로 치료받은 피험자에서 중화 항체 수준 평가용 분석법 및 맞춤 의료에서 이의 사용 |
| TW202515610A (zh) * | 2019-04-22 | 2025-04-16 | 美商美國禮來大藥廠 | 治療克隆氏症(crohn's disease)的方法 |
-
2020
- 2020-04-14 TW TW113124301A patent/TW202515610A/zh unknown
- 2020-04-14 TW TW109112447A patent/TWI850365B/zh active
- 2020-04-15 UA UAA202105413A patent/UA128657C2/uk unknown
- 2020-04-15 KR KR1020217034113A patent/KR102869852B1/ko active Active
- 2020-04-15 BR BR112021018930A patent/BR112021018930A2/pt unknown
- 2020-04-15 CN CN202080030747.5A patent/CN113677366A/zh active Pending
- 2020-04-15 JP JP2021562882A patent/JP7297930B2/ja active Active
- 2020-04-15 SG SG11202110619XA patent/SG11202110619XA/en unknown
- 2020-04-15 CN CN202411949868.6A patent/CN119700968A/zh active Pending
- 2020-04-15 WO PCT/US2020/028273 patent/WO2020219314A1/en not_active Ceased
- 2020-04-15 EA EA202192532A patent/EA202192532A1/ru unknown
- 2020-04-15 MA MA055756A patent/MA55756A/fr unknown
- 2020-04-15 MX MX2021012848A patent/MX2021012848A/es unknown
- 2020-04-15 EP EP20724301.5A patent/EP3958897B1/en active Active
- 2020-04-15 KR KR1020257033226A patent/KR20250153865A/ko active Pending
- 2020-04-15 AU AU2020263238A patent/AU2020263238C1/en active Active
- 2020-04-15 IL IL286818A patent/IL286818B2/en unknown
-
2021
- 2021-10-21 US US17/507,414 patent/US20220040299A1/en active Pending
- 2021-10-21 ZA ZA2021/08094A patent/ZA202108094B/en unknown
-
2023
- 2023-06-14 JP JP2023097427A patent/JP7761614B2/ja active Active
- 2023-11-13 AU AU2023265759A patent/AU2023265759A1/en active Pending
-
2025
- 2025-07-10 JP JP2025116307A patent/JP2025148449A/ja active Pending
- 2025-10-19 IL IL324048A patent/IL324048A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA202192532A1 (ru) | 2022-01-21 |
| IL286818A (en) | 2021-10-31 |
| MX2021012848A (es) | 2021-12-10 |
| IL286818B2 (en) | 2026-03-01 |
| BR112021018930A2 (pt) | 2022-01-18 |
| IL324048A (en) | 2025-12-01 |
| JP7761614B2 (ja) | 2025-10-28 |
| NZ781127A (en) | 2025-06-27 |
| JP2025148449A (ja) | 2025-10-07 |
| CN113677366A (zh) | 2021-11-19 |
| AU2020263238B2 (en) | 2023-08-17 |
| ZA202108094B (en) | 2025-05-28 |
| JP2022530397A (ja) | 2022-06-29 |
| CN119700968A (zh) | 2025-03-28 |
| KR20210142704A (ko) | 2021-11-25 |
| WO2020219314A1 (en) | 2020-10-29 |
| KR20250153865A (ko) | 2025-10-27 |
| KR102869852B1 (ko) | 2025-10-14 |
| UA128657C2 (uk) | 2024-09-18 |
| TW202515610A (zh) | 2025-04-16 |
| AU2020263238A1 (en) | 2021-11-04 |
| JP7297930B2 (ja) | 2023-06-26 |
| MA55756A (fr) | 2022-03-02 |
| EP3958897B1 (en) | 2026-05-06 |
| AU2020263238C1 (en) | 2024-02-22 |
| EP3958897A1 (en) | 2022-03-02 |
| JP2023116680A (ja) | 2023-08-22 |
| CA3134587A1 (en) | 2020-10-29 |
| TW202103734A (zh) | 2021-02-01 |
| TWI850365B (zh) | 2024-08-01 |
| US20220040299A1 (en) | 2022-02-10 |
| AU2023265759A1 (en) | 2023-12-07 |
| IL286818B1 (en) | 2025-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL268327A (en) | A pharmaceutical preparation for use in the treatment and prevention of c5-related diseases and methods for the treatment and prevention of c5-related diseases | |
| PT3873604T (pt) | Métodos para tratar a doença de alzheimer com hp-[beta]-ciclodextrina | |
| IL277498A (en) | Compounds for the treatment of Huntington's disease | |
| IL287945A (en) | Compounds for the treatment of Huntington's disease | |
| IL271046B1 (en) | Compounds for the treatment of Huntington's disease | |
| SG11202013239RA (en) | Composition and method for treating pain | |
| IL277182A (en) | Compositions and methods for treating Parkinson's disease | |
| SG10202002898RA (en) | A Pharmaceutical Composition For Use In The Treatment Or Prevention Of A C5-Related Disease And A Method For Treating Or Preventing A C5-Related Disease | |
| LT4004022T (lt) | Medžiagos ir metodai, skirti fridraicho ataksijos gydymui | |
| IL276896A (en) | Methods for treating Crohn's disease with a specific anti-IL23 antibody | |
| GB201714027D0 (en) | Antisense oligonucleotides for the treatment of huntington's disease | |
| IL283654A (en) | Decarboxylase inhibitors for the treatment of Parkinson's disease | |
| SG11202106794WA (en) | Method for treating lower back pain | |
| PL4076461T3 (pl) | Lumateperon do stosowania w leczeniu schizofrenii | |
| ES3064246T3 (en) | Compounds for use in methods for treating alzheimer's disease | |
| SG11202110619XA (en) | Mirikizumab for use in a method of treating crohn's disease | |
| ZA202107235B (en) | Compositions and methods for treating ocular disease | |
| IL284629A (en) | Methods for treating eye surface pain | |
| IL290770A (en) | Compounds and methods for treating oxalate-related diseases | |
| IL290726A (en) | Use of Brazicomb to treat Crohn's disease | |
| IL290046A (en) | Methods and materials for the treatment of acute neuroinflammatory injury | |
| SI4072532T1 (sl) | Dozirna oblika za uporabo v zdravljenju ali preprečevanju bolezni | |
| SG11202109180RA (en) | Compositions and methods for treating huntington's disease | |
| HK40060614A (en) | Mirikizumab for use in a method of treating crohn's disease | |
| PL3846788T3 (pl) | Inhibitory pde11 do zastosowania w leczeniu choroby parkinsona |